Michael A Cantrell

Title: Innovations of Michael A. Cantrell

Introduction

Michael A. Cantrell is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the area of interleukin-2 research. With a total of 2 patents, his work has advanced the understanding and application of this important cytokine.

Latest Patents

Michael A. Cantrell's latest patents include a process for preparing bovine interleukin-2 and DNA sequences encoding bovine interleukin-2. The first patent describes a method for culturing a microbial host transformed by a vector containing a DNA sequence encoding bIL-2. This process allows for the expression and recovery of bIL-2. The second patent involves a chemically-synthesized oligonucleotide that serves as a probe to isolate the gene coding for human IL-2. This innovative approach utilizes double-stranded cDNA prepared from bovine cells to express recombinant bovine IL-2 in yeast and bacterial systems.

Career Highlights

Throughout his career, Michael has worked with notable companies, including Immunex Corporation. His expertise in biotechnology has positioned him as a key figure in the development of therapeutic applications involving interleukin-2.

Collaborations

Michael A. Cantrell has collaborated with esteemed colleagues such as Dirk M. Anderson and Paul E. Baker. These partnerships have further enriched his research and contributed to the advancement of his innovative projects.

Conclusion

Michael A. Cantrell's contributions to biotechnology, particularly in the realm of interleukin-2, showcase his dedication to innovation and research. His patents reflect a commitment to advancing scientific knowledge and therapeutic applications.